• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Global Veterinary Dermatology Drugs Market Insights, Forecast to 2026

report cover
  • 22 June 2020
  • Healthcare
  • 118 Pages
  • Report Code: 24LS-8523
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Veterinary Dermatology Drugs -MARKET ADVISORY SERVICES

Veterinary Dermatology Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Veterinary Dermatology Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Veterinary Dermatology Drugs market is segmented into
Antibiotics
NSAIDS
Veterinary Antifungal Drugs
Others

Segment by Application, the Veterinary Dermatology Drugs market is segmented into
Veterinary Clinics
Veterinary Hospitals
Others

Regional and Country-level Analysis
The Veterinary Dermatology Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Veterinary Dermatology Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Veterinary Dermatology Drugs Market Share Analysis
Veterinary Dermatology Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Veterinary Dermatology Drugs business, the date to enter into the Veterinary Dermatology Drugs market, Veterinary Dermatology Drugs product introduction, recent developments, etc.
The major vendors covered:
Bayer Animal Health
Boehringer Ingelheim Vetmedica
Ceva Sante Animale
Com Zoetis Inc.
Elanco
IDEXX Laboratories
Merial
Vetoquinol S.A.panies
Virbac S.A.
1 Study Coverage
1.1 Veterinary Dermatology Drugs Product Introduction
1.2 Market Segments
1.3 Key Veterinary Dermatology Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Veterinary Dermatology Drugs Market Size Growth Rate by Type
1.4.2 Antibiotics
1.4.3 NSAIDS
1.4.4 Veterinary Antifungal Drugs
1.4.5 Others
1.5 Market by Application
1.5.1 Global Veterinary Dermatology Drugs Market Size Growth Rate by Application
1.5.2 Veterinary Clinics
1.5.3 Veterinary Hospitals
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Veterinary Dermatology Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Veterinary Dermatology Drugs Industry
1.6.1.1 Veterinary Dermatology Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Veterinary Dermatology Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Veterinary Dermatology Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Veterinary Dermatology Drugs Market Size Estimates and Forecasts
2.1.1 Global Veterinary Dermatology Drugs Revenue 2015-2026
2.1.2 Global Veterinary Dermatology Drugs Sales 2015-2026
2.2 Veterinary Dermatology Drugs Market Size by Region: 2020 Versus 2026
2.2.1 Global Veterinary Dermatology Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Veterinary Dermatology Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Veterinary Dermatology Drugs Competitor Landscape by Players
3.1 Veterinary Dermatology Drugs Sales by Manufacturers
3.1.1 Veterinary Dermatology Drugs Sales by Manufacturers (2015-2020)
3.1.2 Veterinary Dermatology Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Veterinary Dermatology Drugs Revenue by Manufacturers
3.2.1 Veterinary Dermatology Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Veterinary Dermatology Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Veterinary Dermatology Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Veterinary Dermatology Drugs Revenue in 2019
3.2.5 Global Veterinary Dermatology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Veterinary Dermatology Drugs Price by Manufacturers
3.4 Veterinary Dermatology Drugs Manufacturing Base Distribution, Product Types
3.4.1 Veterinary Dermatology Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Veterinary Dermatology Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Veterinary Dermatology Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Veterinary Dermatology Drugs Market Size by Type (2015-2020)
4.1.1 Global Veterinary Dermatology Drugs Sales by Type (2015-2020)
4.1.2 Global Veterinary Dermatology Drugs Revenue by Type (2015-2020)
4.1.3 Veterinary Dermatology Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Veterinary Dermatology Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Veterinary Dermatology Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Veterinary Dermatology Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Veterinary Dermatology Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Veterinary Dermatology Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)
5.1 Global Veterinary Dermatology Drugs Market Size by Application (2015-2020)
5.1.1 Global Veterinary Dermatology Drugs Sales by Application (2015-2020)
5.1.2 Global Veterinary Dermatology Drugs Revenue by Application (2015-2020)
5.1.3 Veterinary Dermatology Drugs Price by Application (2015-2020)
5.2 Veterinary Dermatology Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Veterinary Dermatology Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Veterinary Dermatology Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Veterinary Dermatology Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Veterinary Dermatology Drugs by Country
6.1.1 North America Veterinary Dermatology Drugs Sales by Country
6.1.2 North America Veterinary Dermatology Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Veterinary Dermatology Drugs Market Facts & Figures by Type
6.3 North America Veterinary Dermatology Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Veterinary Dermatology Drugs by Country
7.1.1 Europe Veterinary Dermatology Drugs Sales by Country
7.1.2 Europe Veterinary Dermatology Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Veterinary Dermatology Drugs Market Facts & Figures by Type
7.3 Europe Veterinary Dermatology Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Veterinary Dermatology Drugs by Region
8.1.1 Asia Pacific Veterinary Dermatology Drugs Sales by Region
8.1.2 Asia Pacific Veterinary Dermatology Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Veterinary Dermatology Drugs Market Facts & Figures by Type
8.3 Asia Pacific Veterinary Dermatology Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Veterinary Dermatology Drugs by Country
9.1.1 Latin America Veterinary Dermatology Drugs Sales by Country
9.1.2 Latin America Veterinary Dermatology Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Veterinary Dermatology Drugs Market Facts & Figures by Type
9.3 Central & South America Veterinary Dermatology Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Veterinary Dermatology Drugs by Country
10.1.1 Middle East and Africa Veterinary Dermatology Drugs Sales by Country
10.1.2 Middle East and Africa Veterinary Dermatology Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Veterinary Dermatology Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Veterinary Dermatology Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 Bayer Animal Health
11.1.1 Bayer Animal Health Corporation Information
11.1.2 Bayer Animal Health Description, Business Overview and Total Revenue
11.1.3 Bayer Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Animal Health Veterinary Dermatology Drugs Products Offered
11.1.5 Bayer Animal Health Recent Development
11.2 Boehringer Ingelheim Vetmedica
11.2.1 Boehringer Ingelheim Vetmedica Corporation Information
11.2.2 Boehringer Ingelheim Vetmedica Description, Business Overview and Total Revenue
11.2.3 Boehringer Ingelheim Vetmedica Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Boehringer Ingelheim Vetmedica Veterinary Dermatology Drugs Products Offered
11.2.5 Boehringer Ingelheim Vetmedica Recent Development
11.3 Ceva Sante Animale
11.3.1 Ceva Sante Animale Corporation Information
11.3.2 Ceva Sante Animale Description, Business Overview and Total Revenue
11.3.3 Ceva Sante Animale Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Ceva Sante Animale Veterinary Dermatology Drugs Products Offered
11.3.5 Ceva Sante Animale Recent Development
11.4 Com Zoetis Inc.
11.4.1 Com Zoetis Inc. Corporation Information
11.4.2 Com Zoetis Inc. Description, Business Overview and Total Revenue
11.4.3 Com Zoetis Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Com Zoetis Inc. Veterinary Dermatology Drugs Products Offered
11.4.5 Com Zoetis Inc. Recent Development
11.5 Elanco
11.5.1 Elanco Corporation Information
11.5.2 Elanco Description, Business Overview and Total Revenue
11.5.3 Elanco Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Elanco Veterinary Dermatology Drugs Products Offered
11.5.5 Elanco Recent Development
11.6 IDEXX Laboratories
11.6.1 IDEXX Laboratories Corporation Information
11.6.2 IDEXX Laboratories Description, Business Overview and Total Revenue
11.6.3 IDEXX Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.6.4 IDEXX Laboratories Veterinary Dermatology Drugs Products Offered
11.6.5 IDEXX Laboratories Recent Development
11.7 Merial
11.7.1 Merial Corporation Information
11.7.2 Merial Description, Business Overview and Total Revenue
11.7.3 Merial Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merial Veterinary Dermatology Drugs Products Offered
11.7.5 Merial Recent Development
11.8 Vetoquinol S.A.panies
11.8.1 Vetoquinol S.A.panies Corporation Information
11.8.2 Vetoquinol S.A.panies Description, Business Overview and Total Revenue
11.8.3 Vetoquinol S.A.panies Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Vetoquinol S.A.panies Veterinary Dermatology Drugs Products Offered
11.8.5 Vetoquinol S.A.panies Recent Development
11.9 Virbac S.A.
11.9.1 Virbac S.A. Corporation Information
11.9.2 Virbac S.A. Description, Business Overview and Total Revenue
11.9.3 Virbac S.A. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Virbac S.A. Veterinary Dermatology Drugs Products Offered
11.9.5 Virbac S.A. Recent Development
11.1 Bayer Animal Health
11.1.1 Bayer Animal Health Corporation Information
11.1.2 Bayer Animal Health Description, Business Overview and Total Revenue
11.1.3 Bayer Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Animal Health Veterinary Dermatology Drugs Products Offered
11.1.5 Bayer Animal Health Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Veterinary Dermatology Drugs Market Estimates and Projections by Region
12.1.1 Global Veterinary Dermatology Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Veterinary Dermatology Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Veterinary Dermatology Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Veterinary Dermatology Drugs Sales Forecast (2021-2026)
12.2.2 North America: Veterinary Dermatology Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Veterinary Dermatology Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Veterinary Dermatology Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Veterinary Dermatology Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Veterinary Dermatology Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Veterinary Dermatology Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Veterinary Dermatology Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Veterinary Dermatology Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Veterinary Dermatology Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Veterinary Dermatology Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Veterinary Dermatology Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Veterinary Dermatology Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Veterinary Dermatology Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Veterinary Dermatology Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Veterinary Dermatology Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Veterinary Dermatology Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Veterinary Dermatology Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Veterinary Dermatology Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Veterinary Dermatology Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Veterinary Dermatology Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables

Table 1. Veterinary Dermatology Drugs Market Segments

Table 2. Ranking of Global Top Veterinary Dermatology Drugs Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Veterinary Dermatology Drugs Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)

Table 4. Major Manufacturers of Antibiotics

Table 5. Major Manufacturers of NSAIDS

Table 6. Major Manufacturers of Veterinary Antifungal Drugs

Table 7. Major Manufacturers of Others

Table 8. COVID-19 Impact Global Market: (Four Veterinary Dermatology Drugs Market Size Forecast Scenarios)

Table 9. Opportunities and Trends for Veterinary Dermatology Drugs Players in the COVID-19 Landscape

Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 11. Key Regions/Countries Measures against Covid-19 Impact

Table 12. Proposal for Veterinary Dermatology Drugs Players to Combat Covid-19 Impact

Table 13. Global Veterinary Dermatology Drugs Market Size Growth Rate by Application 2020-2026 (MT)

Table 14. Global Veterinary Dermatology Drugs Market Size by Region (MT) & (US$ Million): 2020 VS 2026

Table 15. Global Veterinary Dermatology Drugs Sales by Regions 2015-2020 (MT)

Table 16. Global Veterinary Dermatology Drugs Sales Market Share by Regions (2015-2020)

Table 17. Global Veterinary Dermatology Drugs Revenue by Regions 2015-2020 (US$ Million)

Table 18. Global Veterinary Dermatology Drugs Sales by Manufacturers (2015-2020) (MT)

Table 19. Global Veterinary Dermatology Drugs Sales Share by Manufacturers (2015-2020)

Table 20. Global Veterinary Dermatology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 21. Global Veterinary Dermatology Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Dermatology Drugs as of 2019)

Table 22. Veterinary Dermatology Drugs Revenue by Manufacturers (2015-2020) (US$ Million)

Table 23. Veterinary Dermatology Drugs Revenue Share by Manufacturers (2015-2020)

Table 24. Key Manufacturers Veterinary Dermatology Drugs Price (2015-2020) (USD/Kg)

Table 25. Veterinary Dermatology Drugs Manufacturers Manufacturing Base Distribution and Headquarters

Table 26. Manufacturers Veterinary Dermatology Drugs Product Type

Table 27. Date of International Manufacturers Enter into Veterinary Dermatology Drugs Market

Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 29. Global Veterinary Dermatology Drugs Sales by Type (2015-2020) (MT)

Table 30. Global Veterinary Dermatology Drugs Sales Share by Type (2015-2020)

Table 31. Global Veterinary Dermatology Drugs Revenue by Type (2015-2020) (US$ Million)

Table 32. Global Veterinary Dermatology Drugs Revenue Share by Type (2015-2020)

Table 33. Veterinary Dermatology Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)

Table 34. Global Veterinary Dermatology Drugs Sales by Application (2015-2020) (MT)

Table 35. Global Veterinary Dermatology Drugs Sales Share by Application (2015-2020)

Table 36. North America Veterinary Dermatology Drugs Sales by Country (2015-2020) (MT)

Table 37. North America Veterinary Dermatology Drugs Sales Market Share by Country (2015-2020)

Table 38. North America Veterinary Dermatology Drugs Revenue by Country (2015-2020) (US$ Million)

Table 39. North America Veterinary Dermatology Drugs Revenue Market Share by Country (2015-2020)

Table 40. North America Veterinary Dermatology Drugs Sales by Type (2015-2020) (MT)

Table 41. North America Veterinary Dermatology Drugs Sales Market Share by Type (2015-2020)

Table 42. North America Veterinary Dermatology Drugs Sales by Application (2015-2020) (MT)

Table 43. North America Veterinary Dermatology Drugs Sales Market Share by Application (2015-2020)

Table 44. Europe Veterinary Dermatology Drugs Sales by Country (2015-2020) (MT)

Table 45. Europe Veterinary Dermatology Drugs Sales Market Share by Country (2015-2020)

Table 46. Europe Veterinary Dermatology Drugs Revenue by Country (2015-2020) (US$ Million)

Table 47. Europe Veterinary Dermatology Drugs Revenue Market Share by Country (2015-2020)

Table 48. Europe Veterinary Dermatology Drugs Sales by Type (2015-2020) (MT)

Table 49. Europe Veterinary Dermatology Drugs Sales Market Share by Type (2015-2020)

Table 50. Europe Veterinary Dermatology Drugs Sales by Application (2015-2020) (MT)

Table 51. Europe Veterinary Dermatology Drugs Sales Market Share by Application (2015-2020)

Table 52. Asia Pacific Veterinary Dermatology Drugs Sales by Region (2015-2020) (MT)

Table 53. Asia Pacific Veterinary Dermatology Drugs Sales Market Share by Region (2015-2020)

Table 54. Asia Pacific Veterinary Dermatology Drugs Revenue by Region (2015-2020) (US$ Million)

Table 55. Asia Pacific Veterinary Dermatology Drugs Revenue Market Share by Region (2015-2020)

Table 56. Asia Pacific Veterinary Dermatology Drugs Sales by Type (2015-2020) (MT)

Table 57. Asia Pacific Veterinary Dermatology Drugs Sales Market Share by Type (2015-2020)

Table 58. Asia Pacific Veterinary Dermatology Drugs Sales by Application (2015-2020) (MT)

Table 59. Asia Pacific Veterinary Dermatology Drugs Sales Market Share by Application (2015-2020)

Table 60. Latin America Veterinary Dermatology Drugs Sales by Country (2015-2020) (MT)

Table 61. Latin America Veterinary Dermatology Drugs Sales Market Share by Country (2015-2020)

Table 62. Latin Americaa Veterinary Dermatology Drugs Revenue by Country (2015-2020) (US$ Million)

Table 63. Latin America Veterinary Dermatology Drugs Revenue Market Share by Country (2015-2020)

Table 64. Latin America Veterinary Dermatology Drugs Sales by Type (2015-2020) (MT)

Table 65. Latin America Veterinary Dermatology Drugs Sales Market Share by Type (2015-2020)

Table 66. Latin America Veterinary Dermatology Drugs Sales by Application (2015-2020) (MT)

Table 67. Latin America Veterinary Dermatology Drugs Sales Market Share by Application (2015-2020)

Table 68. Middle East and Africa Veterinary Dermatology Drugs Sales by Country (2015-2020) (MT)

Table 69. Middle East and Africa Veterinary Dermatology Drugs Sales Market Share by Country (2015-2020)

Table 70. Middle East and Africa Veterinary Dermatology Drugs Revenue by Country (2015-2020) (US$ Million)

Table 71. Middle East and Africa Veterinary Dermatology Drugs Revenue Market Share by Country (2015-2020)

Table 72. Middle East and Africa Veterinary Dermatology Drugs Sales by Type (2015-2020) (MT)

Table 73. Middle East and Africa Veterinary Dermatology Drugs Sales Market Share by Type (2015-2020)

Table 74. Middle East and Africa Veterinary Dermatology Drugs Sales by Application (2015-2020) (MT)

Table 75. Middle East and Africa Veterinary Dermatology Drugs Sales Market Share by Application (2015-2020)

Table 76. Bayer Animal Health Corporation Information

Table 77. Bayer Animal Health Description and Major Businesses

Table 78. Bayer Animal Health Veterinary Dermatology Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 79. Bayer Animal Health Product

Table 80. Bayer Animal Health Recent Development

Table 81. Boehringer Ingelheim Vetmedica Corporation Information

Table 82. Boehringer Ingelheim Vetmedica Description and Major Businesses

Table 83. Boehringer Ingelheim Vetmedica Veterinary Dermatology Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 84. Boehringer Ingelheim Vetmedica Product

Table 85. Boehringer Ingelheim Vetmedica Recent Development

Table 86. Ceva Sante Animale Corporation Information

Table 87. Ceva Sante Animale Description and Major Businesses

Table 88. Ceva Sante Animale Veterinary Dermatology Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 89. Ceva Sante Animale Product

Table 90. Ceva Sante Animale Recent Development

Table 91. Com Zoetis Inc. Corporation Information

Table 92. Com Zoetis Inc. Description and Major Businesses

Table 93. Com Zoetis Inc. Veterinary Dermatology Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 94. Com Zoetis Inc. Product

Table 95. Com Zoetis Inc. Recent Development

Table 96. Elanco Corporation Information

Table 97. Elanco Description and Major Businesses

Table 98. Elanco Veterinary Dermatology Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 99. Elanco Product

Table 100. Elanco Recent Development

Table 101. IDEXX Laboratories Corporation Information

Table 102. IDEXX Laboratories Description and Major Businesses

Table 103. IDEXX Laboratories Veterinary Dermatology Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 104. IDEXX Laboratories Product

Table 105. IDEXX Laboratories Recent Development

Table 106. Merial Corporation Information

Table 107. Merial Description and Major Businesses

Table 108. Merial Veterinary Dermatology Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 109. Merial Product

Table 110. Merial Recent Development

Table 111. Vetoquinol S.A.panies Corporation Information

Table 112. Vetoquinol S.A.panies Description and Major Businesses

Table 113. Vetoquinol S.A.panies Veterinary Dermatology Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 114. Vetoquinol S.A.panies Product

Table 115. Vetoquinol S.A.panies Recent Development

Table 116. Virbac S.A. Corporation Information

Table 117. Virbac S.A. Description and Major Businesses

Table 118. Virbac S.A. Veterinary Dermatology Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 119. Virbac S.A. Product

Table 120. Virbac S.A. Recent Development

Table 121. Global Veterinary Dermatology Drugs Sales Forecast by Regions (2021-2026) (MT)

Table 122. Global Veterinary Dermatology Drugs Sales Market Share Forecast by Regions (2021-2026)

Table 123. Global Veterinary Dermatology Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)

Table 124. Global Veterinary Dermatology Drugs Revenue Market Share Forecast by Regions (2021-2026)

Table 125. North America: Veterinary Dermatology Drugs Sales Forecast by Country (2021-2026) (MT)

Table 126. North America: Veterinary Dermatology Drugs Revenue Forecast by Country (2021-2026) (US$ Million)

Table 127. Europe: Veterinary Dermatology Drugs Sales Forecast by Country (2021-2026) (MT)

Table 128. Europe: Veterinary Dermatology Drugs Revenue Forecast by Country (2021-2026) (US$ Million)

Table 129. Asia Pacific: Veterinary Dermatology Drugs Sales Forecast by Region (2021-2026) (MT)

Table 130. Asia Pacific: Veterinary Dermatology Drugs Revenue Forecast by Region (2021-2026) (US$ Million)

Table 131. Latin America: Veterinary Dermatology Drugs Sales Forecast by Country (2021-2026) (MT)

Table 132. Latin America: Veterinary Dermatology Drugs Revenue Forecast by Country (2021-2026) (US$ Million)

Table 133. Middle East and Africa: Veterinary Dermatology Drugs Sales Forecast by Country (2021-2026) (MT)

Table 134. Middle East and Africa: Veterinary Dermatology Drugs Revenue Forecast by Country (2021-2026) (US$ Million)

Table 135. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 136. Key Challenges

Table 137. Market Risks

Table 138. Main Points Interviewed from Key Veterinary Dermatology Drugs Players

Table 139. Veterinary Dermatology Drugs Customers List

Table 140. Veterinary Dermatology Drugs Distributors List

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

List of Figures

Figure 1. Veterinary Dermatology Drugs Product Picture

Figure 2. Global Veterinary Dermatology Drugs Sales Market Share by Type in 2020 & 2026

Figure 3. Antibiotics Product Picture

Figure 4. NSAIDS Product Picture

Figure 5. Veterinary Antifungal Drugs Product Picture

Figure 6. Others Product Picture

Figure 7. Global Veterinary Dermatology Drugs Sales Market Share by Application in 2020 & 2026

Figure 8. Veterinary Clinics

Figure 9. Veterinary Hospitals

Figure 10. Others

Figure 11. Veterinary Dermatology Drugs Report Years Considered

Figure 12. Global Veterinary Dermatology Drugs Market Size 2015-2026 (US$ Million)

Figure 13. Global Veterinary Dermatology Drugs Sales 2015-2026 (MT)

Figure 14. Global Veterinary Dermatology Drugs Market Size Market Share by Region: 2020 Versus 2026

Figure 15. Global Veterinary Dermatology Drugs Sales Market Share by Region (2015-2020)

Figure 16. Global Veterinary Dermatology Drugs Sales Market Share by Region in 2019

Figure 17. Global Veterinary Dermatology Drugs Revenue Market Share by Region (2015-2020)

Figure 18. Global Veterinary Dermatology Drugs Revenue Market Share by Region in 2019

Figure 19. Global Veterinary Dermatology Drugs Sales Share by Manufacturer in 2019

Figure 20. The Top 10 and 5 Players Market Share by Veterinary Dermatology Drugs Revenue in 2019

Figure 21. Veterinary Dermatology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 22. Global Veterinary Dermatology Drugs Sales Market Share by Type (2015-2020)

Figure 23. Global Veterinary Dermatology Drugs Sales Market Share by Type in 2019

Figure 24. Global Veterinary Dermatology Drugs Revenue Market Share by Type (2015-2020)

Figure 25. Global Veterinary Dermatology Drugs Revenue Market Share by Type in 2019

Figure 26. Global Veterinary Dermatology Drugs Market Share by Price Range (2015-2020)

Figure 27. Global Veterinary Dermatology Drugs Sales Market Share by Application (2015-2020)

Figure 28. Global Veterinary Dermatology Drugs Sales Market Share by Application in 2019

Figure 29. Global Veterinary Dermatology Drugs Revenue Market Share by Application (2015-2020)

Figure 30. Global Veterinary Dermatology Drugs Revenue Market Share by Application in 2019

Figure 31. North America Veterinary Dermatology Drugs Sales Growth Rate 2015-2020 (MT)

Figure 32. North America Veterinary Dermatology Drugs Revenue Growth Rate 2015-2020 (US$ Million)

Figure 33. North America Veterinary Dermatology Drugs Sales Market Share by Country in 2019

Figure 34. North America Veterinary Dermatology Drugs Revenue Market Share by Country in 2019

Figure 35. U.S. Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 36. U.S. Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 37. Canada Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 38. Canada Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 39. North America Veterinary Dermatology Drugs Market Share by Type in 2019

Figure 40. North America Veterinary Dermatology Drugs Market Share by Application in 2019

Figure 41. Europe Veterinary Dermatology Drugs Sales Growth Rate 2015-2020 (MT)

Figure 42. Europe Veterinary Dermatology Drugs Revenue Growth Rate 2015-2020 (US$ Million)

Figure 43. Europe Veterinary Dermatology Drugs Sales Market Share by Country in 2019

Figure 44. Europe Veterinary Dermatology Drugs Revenue Market Share by Country in 2019

Figure 45. Germany Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 46. Germany Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 47. France Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 48. France Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 49. U.K. Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 50. U.K. Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 51. Italy Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 52. Italy Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 53. Russia Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 54. Russia Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 55. Europe Veterinary Dermatology Drugs Market Share by Type in 2019

Figure 56. Europe Veterinary Dermatology Drugs Market Share by Application in 2019

Figure 57. Asia Pacific Veterinary Dermatology Drugs Sales Growth Rate 2015-2020 (MT)

Figure 58. Asia Pacific Veterinary Dermatology Drugs Revenue Growth Rate 2015-2020 (US$ Million)

Figure 59. Asia Pacific Veterinary Dermatology Drugs Sales Market Share by Region in 2019

Figure 60. Asia Pacific Veterinary Dermatology Drugs Revenue Market Share by Region in 2019

Figure 61. China Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 62. China Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 63. Japan Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 64. Japan Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 65. South Korea Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 66. South Korea Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 67. India Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 68. India Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 69. Australia Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 70. Australia Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 71. Taiwan Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 72. Taiwan Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 73. Indonesia Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 74. Indonesia Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 75. Thailand Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 76. Thailand Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 77. Malaysia Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 78. Malaysia Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 79. Philippines Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 80. Philippines Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 81. Vietnam Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 82. Vietnam Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 83. Asia Pacific Veterinary Dermatology Drugs Market Share by Type in 2019

Figure 84. Asia Pacific Veterinary Dermatology Drugs Market Share by Application in 2019

Figure 85. Latin America Veterinary Dermatology Drugs Sales Growth Rate 2015-2020 (MT)

Figure 86. Latin America Veterinary Dermatology Drugs Revenue Growth Rate 2015-2020 (US$ Million)

Figure 87. Latin America Veterinary Dermatology Drugs Sales Market Share by Country in 2019

Figure 88. Latin America Veterinary Dermatology Drugs Revenue Market Share by Country in 2019

Figure 89. Mexico Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 90. Mexico Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 91. Brazil Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 92. Brazil Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 93. Argentina Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 94. Argentina Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 95. Latin America Veterinary Dermatology Drugs Market Share by Type in 2019

Figure 96. Latin America Veterinary Dermatology Drugs Market Share by Application in 2019

Figure 97. Middle East and Africa Veterinary Dermatology Drugs Sales Growth Rate 2015-2020 (MT)

Figure 98. Middle East and Africa Veterinary Dermatology Drugs Revenue Growth Rate 2015-2020 (US$ Million)

Figure 99. Middle East and Africa Veterinary Dermatology Drugs Sales Market Share by Country in 2019

Figure 100. Middle East and Africa Veterinary Dermatology Drugs Revenue Market Share by Country in 2019

Figure 101. Turkey Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 102. Turkey Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 103. Saudi Arabia Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 104. Saudi Arabia Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 105. U.A.E Veterinary Dermatology Drugs Sales Growth Rate (2015-2020) (MT)

Figure 106. U.A.E Veterinary Dermatology Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 107. Middle East and Africa Veterinary Dermatology Drugs Market Share by Type in 2019

Figure 108. Middle East and Africa Veterinary Dermatology Drugs Market Share by Application in 2019

Figure 109. Bayer Animal Health Total Revenue (US$ Million): 2019 Compared with 2018

Figure 110. Boehringer Ingelheim Vetmedica Total Revenue (US$ Million): 2019 Compared with 2018

Figure 111. Ceva Sante Animale Total Revenue (US$ Million): 2019 Compared with 2018

Figure 112. Com Zoetis Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 113. Elanco Total Revenue (US$ Million): 2019 Compared with 2018

Figure 114. IDEXX Laboratories Total Revenue (US$ Million): 2019 Compared with 2018

Figure 115. Merial Total Revenue (US$ Million): 2019 Compared with 2018

Figure 116. Vetoquinol S.A.panies Total Revenue (US$ Million): 2019 Compared with 2018

Figure 117. Virbac S.A. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 118. North America Veterinary Dermatology Drugs Sales Growth Rate Forecast (2021-2026) (MT)

Figure 119. North America Veterinary Dermatology Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 120. Europe Veterinary Dermatology Drugs Sales Growth Rate Forecast (2021-2026) (MT)

Figure 121. Europe Veterinary Dermatology Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 122. Asia Pacific Veterinary Dermatology Drugs Sales Growth Rate Forecast (2021-2026) (MT)

Figure 123. Asia Pacific Veterinary Dermatology Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 124. Latin America Veterinary Dermatology Drugs Sales Growth Rate Forecast (2021-2026) (MT)

Figure 125. Latin America Veterinary Dermatology Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 126. Middle East and Africa Veterinary Dermatology Drugs Sales Growth Rate Forecast (2021-2026) (MT)

Figure 127. Middle East and Africa Veterinary Dermatology Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 128. Porter's Five Forces Analysis

Figure 129. Channels of Distribution

Figure 130. Distributors Profiles

Figure 131. Bottom-up and Top-down Approaches for This Report

Figure 132. Data Triangulation

Figure 133. Key Executives Interviewed

Bayer Animal Health

Boehringer Ingelheim Vetmedica

Ceva Sante Animale

Com Zoetis Inc.

Elanco

IDEXX Laboratories

Merial

Vetoquinol S.A.panies

Virbac S.A.

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3159

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase